Last reviewed · How we verify

NCT05021575: COVID-COR-LT

Effects of COVID-19 Pandemic on a Health Care System: Case Study of the CirculatORy System in LiThuania

Completed Last updated 31 August 2021
What this trial tests

trial testing Data collection on outpatient care in Cardiovascular Diseases in 839,678 participants. Completed in 31 December 2020.

Timeline
1 June 2020
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorVilnius University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment839,678
Start date1 June 2020
Primary completion31 December 2020
Estimated completion31 December 2020
Sites3 locations across Lithuania

Drugs / interventions tested

Conditions studied

Sponsor

Vilnius University

Who can join

18 and older, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coronavirus disease of 2019 (COVID-19) affected the health care systems all around the world. The collateral damage of the pandemic on the cardiovascular (CV) care and CV mortality has been noticed and reported early. In Lithuania, first quarantine measurements were introduced on 16th March and lifted on 16th June of 2020, limiting contact appointments to urgent care only. This led to a substantial proportion of routine cardiovascular appointments, diagnostic and therapeutic procedures being cancelled and greatly limited the availability of cardiovascular care. The prognostic impact of this has not been appropriately analysed. Also, comprehensive analyses of the changes in national CV services, including outpatient care and hospitalisations and CV mortality, during different periods of the pandemic (during first and second waves and in between) are scarce. The objectives of this population-based study were: (1) to assess the impact of the COVID-19 pandemic on CV care (2) to compare rates of outpatient care visits and hospitalisations of cardiovascular patients in different periods of 2019 and 2020 (3) to compare the rates of CV mortality in Lithuania in different periods of 2019 and 2020 (4) to investigate sex and age differences in CV care and CV mortality

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Collateral effect of the COVID-19 pandemic on cardiology service provision and cardiovascular mortality in a population-based study: COVID-COR-LT.
    Čelutkienė J, Čerlinskaitė-Bajorė K, Bajoras V, Višinskienė R, et al · · 2022 · cited 4× · PMID 35552504 · DOI 10.1007/s00392-022-02033-y
  2. SEX-SPECIFIC STUDY ON THE COLLATERAL EFFECT OF COVID-19 PANDEMIC
    · 2022

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Vilnius University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05021575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing